IOTR vs IQST

The company exhibits severe financial distress, highlighted by a weak Piotroski F-Score of 2/9 and a catastrophic 1-year price decline of 92.1%. While revenue growth is strong at 39.8%, it has failed to translate into profitability, with negative profit margins and a negative ROE of -12.75%. The stock is currently in a deep bearish technical trend, and its micro-cap status combined with a lack of analyst coverage increases speculative risk. Despite a recent short-term bounce, the fundamental health is insufficient to support a bullish outlook.

The company exhibits severe financial distress, highlighted by a critical Piotroski F-Score of 1/9, indicating fundamental weakness across almost all health metrics. Despite a low Price-to-Book ratio of 0.54, the business is destroying shareholder value with an ROE of -60.40% and declining quarterly revenue (-14.83%). The stock is in a precipitous long-term decline, losing 97% of its value over five years, and the single analyst target of $18.00 appears completely decoupled from current market reality and financial performance.